International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Veterinary Compounding for Myasthenia Gravis

Author(s): Davidson Gigi S

Issue: Sep/Oct 2008 - Veterinary Compounding
View All Articles in Issue

Page(s): 398-401

Veterinary Compounding for Myasthenia Gravis Page 1

Veterinary Compounding for Myasthenia Gravis Page 2

Veterinary Compounding for Myasthenia Gravis Page 3

Veterinary Compounding for Myasthenia Gravis Page 4

Download in electronic PDF format for $75

Abstract: Myasthenia gravis is a neuromuscular disease commonly encountered in veterinary medicine. With accurate diagnosis, treatment, and compliant caregivers, the prognosis for remission and a normal life is good. Unfortunately, drugs used to diagnose and treat myasthenia gravis are frequently unavailable due to manufacturer shortages. During these periods, compounding pharmacists can play a valuable role in maintaining a good quality of life for these patients by providing compounded versions of drugs that are commercially unavailable.

Related Keywords: Gigi S. Davidson, BSPh, DIVCP, FSVHP, formulations, myasthenia gravis, muscle disorders, dogs, veterinary medicine, muscle weakness, cats, edrophomium hydrochloride, acetylcholinesterase inhibitor, acetycholine, neurotransmitter, anticholinesterase agents, pyridostigmine bromide, cellulose, methylcellulose, excipients

Related Categories: EXCIPIENTS, FORMULATIONS, VETERINARY, MUSCULOSKELETAL DISORDERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Veterinary Compounding for Myasthenia Gravis Davidson Gigi S	Sep/Oct 2008 Pg. 398-401
Navigating New Territories in Compounding for Veterinary Medicine Davidson Gigi S	Sep/Oct 2002 Pg. 324-327
The Use of Psychoactive Agents in Veterinary Medicine Simpson Barbara S	Mar/Apr 2001 Pg. 86-88
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2 Davidson Gigi S	May/Jun 2001 Pg. 214-215
Canine Public Servants: Caring for Drug Detection Dogs Davidson Gigi S	Sep/Oct 2008 Pg. 384-390
To Compound or Not to Compound: A Veterinary Transdermal Discussion Eichstadt Lauren R, Davidson Gigi S	Sep/Oct 2014 Pg. 366-369
The Current Landscape of Veterinary Compounding in the Veterinary Setting Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R	Sep/Oct 2019 Pg. 428-433
Drug Therapy for Acute and Chronic Pain in the Cat Lascelles B Duncan	Sep/Oct 2002 Pg. 338-343
Book Reviews: Veterinary Compounding Reed-Kane Dana	Mar/Apr 2001 Pg. 108-109
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Allen Loyd V Jr	May/Jun 2017 Pg. 234
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1 Davidson Gigi S	Mar/Apr 2001 Pg. 95-96
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Davidson Gigi S	Jul/Aug 2004 Pg. 277-283
Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients Davidson Gigi S	Sep/Oct 2007 Pg. 390-395
The Current Landscape of Veterinary Compounding in the Pharmacy Setting Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R	Sep/Oct 2019 Pg. 422-427
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc	Jan/Feb 2014 Pg. 6-12
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Allen Loyd V Jr	Jul/Aug 2020 Pg. 313
United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine DeVeau Ian	Sep/Oct 2007 Pg. 357-362
Return to Top